Table I: Non-GAAP income tax expense |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
Q3'19 |
|
Q2'19 |
|
Q3'18 |
|
Q3'19 |
|
Q3'18 |
||||||||||
GAAP income tax provision [i] |
|
$ |
16,247 |
|
|
$ |
(18,189 |
) |
|
$ |
5,618 |
|
|
$ |
(2,672 |
) |
|
$ |
15,829 |
|
[1] Tax impact of non-GAAP adjustments* relating to: |
|
|
|
|
|
|
|
|
|
|
||||||||||
[a] Stock-based compensation |
|
5,227 |
|
|
6,401 |
|
|
5,081 |
|
|
15,911 |
|
|
16,078 |
|
|||||
[b] Changes in value of deferred compensation plan |
|
32 |
|
|
51 |
|
|
97 |
|
|
209 |
|
|
189 |
|
|||||
[c] Share in gain/loss, net and impairment of equity method investees |
|
290 |
|
|
6,805 |
|
|
768 |
|
|
7,849 |
|
|
2,283 |
|
|||||
[d] Imputed interest on convertible debt, equity component amortization on convertible debt and others |
|
651 |
|
|
688 |
|
|
1,424 |
|
|
2,046 |
|
|
3,072 |
|
|||||
| [e] Amortization of debt issuance costs |
|
131 |
|
|
195 |
|
|
— |
|
|
521 |
|
|
225 |
|
|||||
| [f] Amortization of acquisition-related intangible assets and other |
|
10,793 |
|
|
10,835 |
|
|
11,734 |
|
|
32,659 |
|
|
34,494 |
|
|||||
| [g] Restructuring charges and other |
|
82 |
|
|
620 |
|
|
2,098 |
|
|
723 |
|
|
3,218 |
|
|||||
| [h] Other (income) and expenses |
|
6 |
|
|
— |
|
|
— |
|
|
165 |
|
|
— |
|
|||||
| [i] Loss on extinguishment of debt |
|
1,344 |
|
|
— |
|
|
— |
|
|
1,344 |
|
|
684 |
|
|||||
| [j] (Gain) loss on sale of NAND business to joint venture |
|
(396 |
) |
|
— |
|
|
— |
|
|
346 |
|
|
— |
|
|||||
| [k] Gain on sale of cost method investment |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(319 |
) |
|||||
| [2] Merger-related expenses |
|
639 |
|
|
1,766 |
|
|
— |
|
|
2,405 |
|
|
— |
|
|||||
| [3] Uncertain tax positions |
|
(6,675 |
) |
|
2,621 |
|
|
(2,159 |
) |
|
(3,757 |
) |
|
(4,870 |
) |
|||||
| [4] Valuation allowance release, utilization of NOL including excess tax benefits, and other items** |
|
(25,704 |
) |
|
(9,662 |
) |
|
(21,882 |
) |
|
(50,273 |
) |
|
(61,966 |
) |
|||||
| Non-GAAP income tax expense [ii]* |
|
$ |
2,667 |
|
|
$ |
2,131 |
|
|
$ |
2,779 |
|
|
$ |
7,476 |
|
|
$ |
8,917 |
|
| Impact of reconciling items on income tax provision [i - ii] |
|
13,580 |
|
|
(20,320 |
) |
|
2,839 |
|
|
(10,148 |
) |
|
6,912 |
|
|||||
|
Cypress Reports Third Quarter 2019 Results and Provides Update on Regulatory Approvals
1. The three months ended Q2'19 and the nine months ended Q3'19 include a $29.5 million impairment charge recorded for the investment in Deca Technologies, Inc.
|
|
||||||
|
|
|||||||
|
|||||||
